News

Brand-drug costs rising faster than inflation


 

The cost of brand drugs increased 12.5% last year, far outpacing inflation overall, Express Scripts said in its annual Drug Trend Report.

The overall U.S. inflation rate, according to the Bureau of Labor Statistics, was only 1.7% in 2012.

From January 2008 to December 2012, the cost of an "unchanged market basket of brand drugs rose from $100 to $165.44," Express Scripts said in the report, while the Consumer Price Index, which measures a broad selection of goods and services, went from $100 to $108.80.

The cost of an unchanged selection of generic drugs did the opposite over the same 5-year period, dropping to $57.38 by the end of 2012, according to the report. All dollar values have been adjusted to 2008 dollars.

In 2012 alone, the cost of generic drugs dropped by 24.4%, following decreases of 3.7% in 2011, 14.7% in 2010, and 0.5% in 2009. The price of brand drugs rose 13.6% in 2011, 9.6% in 2010, and 9.1% in 2009, the report noted.

rfranki@frontlinemedcom.com

Recommended Reading

Emergency physicians share lessons from Boston Marathon bombings response
MDedge Neurology
Lawmakers take aim at ACA implementation: The Policy & Practice podcast
MDedge Neurology
Supreme Court ponders patenting of human genes
MDedge Neurology
Navigating the new insurance exchanges
MDedge Neurology
Neurology shortfall to worsen by 2025
MDedge Neurology
U.S. Cymbalta cost highest in international comparison
MDedge Neurology
ACA still not reducing ranks of uninsured
MDedge Neurology
Lower costs documented in hospitals with palliative care programs
MDedge Neurology
Know your values to achieve professional balance
MDedge Neurology
Surgical fellowship directors: General surgery trainees arrive ill prepared
MDedge Neurology